Jiang Yufei, Li Jianing, Li Gaizhen, Liu Songting, Lin Xinjie, He Yan, Lu Jinhua, Zhang Ying, Wu Jinxiang, Yang Zhiping, Jiang Yaling, Wang Haibin, Kong Shuangbo, Shi Guixiu
Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Fujian Provincial Key Laboratory of Reproductive Health Research, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Hum Reprod. 2020 Nov 1;35(11):2439-2453. doi: 10.1093/humrep/deaa233.
Does osteoprotegerin (OPG) promote human endometrial stromal decidualization?
OPG is essential for human endometrial stromal decidualization through its interaction with syndecan-1 to decrease Akt phosphorylation.
OPG (a cytokine receptor) levels are significantly increased in the circulation of pregnant women. However, the role and mechanism of OPG in human endometrial stromal cell (ESC) decidualization remain elusive.
STUDY DESIGN, SIZE, DURATION: We analyzed the endometrial expression of OPG in endometrial tissue samples collected from women with regular menstrual cycles (ranging from 25 to 35 days), and decidual tissue samples collected from woman with normal early pregnancy or recurrent pregnancy loss (RPL) who visited the Department of Gynecology and Obstetrics at a tertiary care center from January to October 2018. None of the subjects had hormonal treatment for at least 3 months prior to the procedure. In total, 16 women with normal early pregnancy and 15 with RPL were selected as subjects for this study. The function of OPG in decidualization was explored in a human endometrial stromal cell (HESC) line and primary cultures of HESCs.
PARTICIPANTS/MATERIALS, SETTING, METHODS: We collected endometrial tissues (by biopsy) from the subjects during their menstrual cycle and decidual tissues from subjects with a normal early pregnancy and those with RPL at the time of dilation and curettage. The control group comprised randomly selected women who underwent termination of an apparently normal early pregnancy. The endometrial OPG expression was analyzed using immunohistochemical staining and quantitative RT-PCR (qRT-PCR). Immunofluorescence staining and western blot, and qRT-PCR were used to explore the mRNA and protein expression, respectively, of OPG in an immortalized HESC line and in primary cultures of HESC during proliferation and decidualization. siRNA-mediated knockdown experiments were performed to examine the function of OPG in HESC proliferation and decidualization. Flow cytometry and the cell proliferation MTS assay were performed to further examine the role of OPG in HESC proliferation. We also analyzed decidual marker gene expression by qRT-PCR to assess the consequences of OPG loss for HESC decidualization. A co-immunoprecipitation (IP) assay was used to determine the potential interaction between the OPG and Syndecan-1. Western blot analysis of the rescue experiments performed using the phosphatidylinositol 3-kinase (PI3K) signaling-specific inhibitor LY294002 was used to investigate the downstream signaling pathways through which OPG could mediate HESC decidualization.
OPG was expressed in both the human endometrium and in vitro decidualized ESCs. Knockdown experiments revealed that OPG loss impaired the expression of IGF-binding protein-1 (IGFBP-1) (P < 0.05) and prolactin (PRL) (P < 0.05), two specific markers of decidualization, in HESC undergoing decidualization. We also uncovered that OPG knockdown induced the aberrant activation of Akt (protein kinase B) during HESC decidualization (P < 0.05). The inhibition of Akt activation could rescue the impaired expression of the decidual markers PRL (P < 0.05) and IGFBP-1 (P < 0.05) in response to OPG knockdown. Syndecan-1 was considered a potential receptor candidate, as it was expressed in both the endometrium and in vitro cultured stromal cells. Subsequent co-IP experiments demonstrated the interaction between OPG and Syndecan-1 during decidualization. In addition, Syndecan-1 knockdown not only clearly attenuated the decidualization markers PRL (P < 0.05) and IGFBP-1 (P < 0.05) but also induced the aberrant enhancement of Akt phosphorylation in decidualized cells, consistent with the phenotype of OPG knockdown cells. Finally, we revealed that the transcript and protein expression of both OPG and Syndecan-1 was significantly lower in the decidual samples of women with RPL than in those of women with normal pregnancy (P < 0.05).
N/A.
LIMITATIONS, REASONS FOR CAUTION: In this study, based on a number of approaches, it was demonstrated that OPG mediated the repression of Akt that occurs during human stromal cell decidualization, however, the molecular link between OPG and Akt signaling was not determined, and still requires further exploration.
OPG is required for decidualization, and a decrease in OPG levels is associated with RPL. These findings provide a new candidate molecule for the diagnosis and potential treatment of RPL.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported in part by the National Natural Science Foundation of China U1605223 (to G.S.), 81701457 (to Y.J.) and 81601349 (to Y.J.). The authors have no conflicts of interest to disclose.
骨保护素(OPG)是否能促进人子宫内膜基质蜕膜化?
OPG通过与syndecan-1相互作用减少Akt磷酸化,对人子宫内膜基质蜕膜化至关重要。
OPG(一种细胞因子受体)在孕妇循环系统中的水平显著升高。然而,OPG在人子宫内膜基质细胞(ESC)蜕膜化中的作用和机制仍不清楚。
研究设计、规模、持续时间:我们分析了从月经周期规律(25至35天)的女性收集的子宫内膜组织样本,以及2018年1月至10月在一家三级医疗中心妇产科就诊的正常早孕或复发性流产(RPL)女性的蜕膜组织样本中OPG的子宫内膜表达。所有受试者在手术前至少3个月未接受激素治疗。总共选择了16名正常早孕女性和15名RPL女性作为本研究的受试者。在人子宫内膜基质细胞(HESC)系和HESC原代培养物中探索OPG在蜕膜化中的功能。
参与者/材料、设置、方法:我们在受试者月经周期期间(通过活检)收集子宫内膜组织,以及在扩张刮宫时从正常早孕和RPL受试者收集蜕膜组织。对照组包括随机选择的接受明显正常早孕终止手术的女性。使用免疫组织化学染色和定量RT-PCR(qRT-PCR)分析子宫内膜OPG表达。免疫荧光染色、western blot和qRT-PCR分别用于探索永生化HESC系和HESC原代培养物在增殖和蜕膜化过程中OPG的mRNA和蛋白质表达。进行siRNA介导的敲低实验以检查OPG在HESC增殖和蜕膜化中的功能。进行流式细胞术和细胞增殖MTS测定以进一步检查OPG在HESC增殖中的作用。我们还通过qRT-PCR分析蜕膜标记基因表达,以评估OPG缺失对HESC蜕膜化的影响。使用免疫共沉淀(IP)测定法确定OPG与Syndecan-1之间的潜在相互作用。使用磷脂酰肌醇3-激酶(PI3K)信号特异性抑制剂LY294002进行的拯救实验的western blot分析用于研究OPG介导HESC蜕膜化的下游信号通路。
OPG在人子宫内膜和体外蜕膜化的ESC中均有表达。敲低实验表明,OPG缺失会损害蜕膜化过程中HESC中胰岛素样生长因子结合蛋白-1(IGFBP-1)(P<0.05)和催乳素(PRL)(P<0.05)这两种蜕膜化特异性标志物的表达。我们还发现,OPG敲低会在HESC蜕膜化过程中诱导Akt(蛋白激酶B)的异常激活(P<0.05)。抑制Akt激活可以挽救因OPG敲低而受损的蜕膜标志物PRL(P<0.05)和IGFBP-1(P<0.05)的表达。Syndecan-1被认为是一种潜在的受体候选物,因为它在子宫内膜和体外培养的基质细胞中均有表达。随后的免疫共沉淀实验证明了蜕膜化过程中OPG与Syndecan-1之间的相互作用。此外,Syndecan-1敲低不仅明显减弱了蜕膜标志物PRL(P<0.05)和IGFBP-1(P<0.05),还诱导了蜕膜化细胞中Akt磷酸化的异常增强,这与OPG敲低细胞的表型一致。最后,我们发现RPL女性蜕膜样本中OPG和Syndecan-1的转录本和蛋白质表达均显著低于正常妊娠女性(P<0.05)。
无。
局限性、谨慎原因:在本研究中,基于多种方法证明了OPG介导人基质细胞蜕膜化过程中发生的Akt抑制,然而,OPG与Akt信号之间的分子联系尚未确定,仍需要进一步探索。
蜕膜化需要OPG,OPG水平降低与RPL相关。这些发现为RPL的诊断和潜在治疗提供了一种新的候选分子。
研究资金/竞争利益:本研究部分得到中国国家自然科学基金U1605223(资助G.S.)、81701457(资助Y.J.)和81601349(资助Y.J.)的支持。作者没有利益冲突需要披露。